Arion Group Corp. (ARGC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Arion Group Corp. (ARGC) trades at $2.50 with AI Score 45/100 (Weak). Arion Group Corp. operates within the dietary supplement and cannabis consulting sectors. Market cap: 20M, Sector: Financial services.
Last analyzed: Mar 15, 2026Arion Group Corp. (ARGC) Financial Services Profile
Arion Group Corp., operating in the financial services sector as a shell company, focuses on the dietary supplement industry and cannabis cultivation consulting. With a negative P/E ratio and volatile stock performance, the company faces significant financial challenges and operates in a speculative market segment.
Investment Thesis
Investing in Arion Group Corp. presents a highly speculative opportunity. The company's negative P/E ratio of -232.84 and a profit margin of -393.5% indicate significant financial challenges. Revenue growth, if any, is a key factor to monitor. The company's involvement in the cannabis cultivation consulting space could provide growth opportunities, but this is subject to regulatory risks and market volatility. The company's beta of -0.14 suggests a low correlation with the overall market, which could offer diversification benefits, but also reflects its unique risk profile. Investors should carefully weigh the potential for high returns against the substantial risk of capital loss.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.02 billion indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -232.84 reflects the company's current lack of profitability.
- Gross margin of 38.9% suggests some efficiency in production and distribution, but is offset by high operating expenses.
- Profit margin of -393.5% highlights substantial losses and operational inefficiencies.
- Beta of -0.14 indicates a negative correlation with the market, suggesting the stock may move independently of broader market trends.
Competitors & Peers
Strengths
- Involvement in the growing dietary supplement market.
- Consulting services in the expanding cannabis cultivation sector.
- Established presence in the United States.
- Potential for innovation in product formulations.
Weaknesses
- Negative profit margin and lack of profitability.
- Limited market capitalization and financial resources.
- Dependence on regulatory changes in the cannabis industry.
- Competition from established players in both sectors.
Catalysts
- Upcoming: Potential regulatory changes in the cannabis industry could create new opportunities for consulting services.
- Ongoing: Increasing consumer demand for dietary supplements may drive revenue growth.
- Ongoing: Strategic partnerships with cultivators and dispensaries could expand market reach.
Risks
- Potential: Changes in regulations could negatively impact the cannabis consulting business.
- Ongoing: Intense competition in the dietary supplement market may limit market share.
- Ongoing: Negative profit margin and lack of profitability pose a significant financial risk.
- Potential: Limited financial disclosure increases the risk of investing in Arion Group Corp.
- Potential: Low trading volume and liquidity can lead to price volatility.
Growth Opportunities
- Expansion of Dietary Supplement Product Line: Arion Group Corp. can expand its product line to include innovative and specialized dietary supplements catering to specific health needs. The global dietary supplements market is projected to reach $287.7 billion by 2028, growing at a CAGR of 9.6%. By focusing on niche markets and developing unique formulations, Arion Group Corp. can capture a larger share of this growing market. Timeline: 2-3 years.
- Strategic Partnerships in Cannabis Cultivation: Forming strategic partnerships with cannabis cultivators and dispensaries can provide Arion Group Corp. with access to a broader customer base and enhance its consulting services. The legal cannabis market is expected to reach $90.4 billion by 2026. These partnerships can also facilitate the development of customized cultivation plans and compliance strategies. Timeline: 1-2 years.
- Geographic Expansion within the United States: Expanding operations to new states within the United States can increase Arion Group Corp.'s market reach and revenue potential. Focusing on states with favorable regulations for dietary supplements and cannabis cultivation can provide a competitive advantage. This expansion requires careful planning and resource allocation. Timeline: 3-5 years.
- Development of Proprietary Formulations: Investing in research and development to create proprietary formulations for dietary supplements can differentiate Arion Group Corp.'s products from competitors. These formulations can target specific health benefits and cater to the growing demand for personalized nutrition. This requires significant investment in scientific research and regulatory compliance. Timeline: 2-4 years.
- Enhancement of Online Presence and E-commerce Capabilities: Strengthening its online presence and e-commerce capabilities can enable Arion Group Corp. to reach a wider audience and increase sales of its dietary supplements. Investing in digital marketing, social media engagement, and a user-friendly online platform can enhance brand awareness and customer loyalty. This requires ongoing investment in technology and marketing. Timeline: 1 year.
Opportunities
- Expansion into new geographic markets within the United States.
- Development of strategic partnerships with cultivators and dispensaries.
- Introduction of new and innovative dietary supplement products.
- Increased demand for cannabis cultivation consulting services.
Threats
- Changes in regulations affecting the dietary supplement and cannabis industries.
- Increased competition from larger and more established companies.
- Economic downturn affecting consumer spending on supplements.
- Potential for product liability claims and recalls.
Competitive Advantages
- Proprietary formulations in dietary supplements (if any).
- Expertise in cannabis cultivation planning and compliance.
- Established relationships with suppliers and distributors (if any).
About ARGC
Arion Group Corp., incorporated in 2016 and based in City of Industry, California, operates within the financial services sector, specifically as a shell company. The company's primary activities revolve around the manufacturing and distribution of dietary ingredients and nutritional supplements in the United States. Additionally, Arion Group Corp. provides consulting services to third parties involved in cannabis cultivation, focusing on planning, design, and regulatory compliance. Since its inception, Arion Group Corp. has navigated the dynamic landscape of the dietary supplement and cannabis industries. The company's business model encompasses both product-based revenue from supplements and service-based revenue from consulting. The company's operations are primarily based in the United States. Arion Group Corp. faces competition from established players in both the dietary supplement and cannabis consulting markets. The company's financial performance, characterized by a negative profit margin, reflects the challenges inherent in these competitive and evolving sectors.
What They Do
- Manufactures and distributes dietary ingredients.
- Manufactures and distributes nutritional supplements.
- Provides consulting services for cannabis cultivation planning.
- Provides consulting services for cannabis cultivation design.
- Provides consulting services for cannabis cultivation compliance.
Business Model
- Generates revenue through the sale of dietary ingredients and nutritional supplements.
- Earns fees by providing consulting services to cannabis cultivators.
- Focuses on serving the United States market.
Industry Context
Arion Group Corp. operates within the shell company segment of the financial services sector, focusing on the dietary supplement and cannabis consulting industries. The dietary supplement market is characterized by increasing consumer awareness of health and wellness, driving demand for various products. The cannabis consulting market is rapidly evolving due to changing regulations and increasing legalization of cannabis in various states. These industries are highly competitive, with numerous players vying for market share. Arion Group Corp.'s success depends on its ability to differentiate its products and services, navigate regulatory hurdles, and achieve profitability in these dynamic markets.
Key Customers
- Consumers seeking dietary ingredients and nutritional supplements.
- Third-party cannabis cultivators requiring planning services.
- Third-party cannabis cultivators requiring design services.
- Third-party cannabis cultivators requiring compliance services.
Financials
Chart & Info
Arion Group Corp. (ARGC) stock price: $2.50 (+0.00, +0.00%)
Latest News
No recent news available for ARGC.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ARGC.
Price Targets
Wall Street price target analysis for ARGC.
MoonshotScore
What does this score mean?
The MoonshotScore rates ARGC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Shell CompaniesLeadership: Jay Hamilton
CEO
Jay Hamilton serves as the CEO of Arion Group Corp. His background includes experience in business management and strategic planning. He has been involved in various aspects of the company's operations, including product development, marketing, and sales. His expertise lies in identifying market opportunities and driving business growth. Prior to joining Arion Group Corp., Hamilton held leadership positions in other companies within the consumer products sector.
Track Record: Under Jay Hamilton's leadership, Arion Group Corp. has focused on expanding its product line and strengthening its market presence. Key achievements include establishing partnerships with distributors and increasing brand awareness. Strategic decisions have centered on investing in research and development to create innovative dietary supplement formulations. The company has also navigated regulatory challenges in the cannabis cultivation sector.
ARGC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by limited disclosure requirements and higher risk. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies often do not meet minimum financial standards and may not be required to file regular reports with the SEC. This lack of transparency increases the potential for fraud and manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in Arion Group Corp.
- Low trading volume and liquidity can lead to price volatility.
- Potential for fraud and manipulation is higher on the OTC market.
- OTC Other companies often have limited operating history and financial resources.
- Dependence on regulatory changes in the cannabis industry adds uncertainty.
- Verify the company's registration and compliance status with regulatory agencies.
- Review available financial statements and assess the company's financial health.
- Research the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the potential risks and challenges facing the company.
- Monitor news and developments related to the company and its industry.
- Consult with a qualified financial advisor before investing.
- Established presence in the dietary supplement market.
- Provision of consulting services in the cannabis cultivation sector.
- Company incorporation in 2016.
- Physical headquarters in City of Industry, California.
- CEO leadership.
Arion Group Corp. Stock: Key Questions Answered
What does Arion Group Corp. do?
Arion Group Corp. operates in the financial services sector as a shell company, focusing on the manufacturing and distribution of dietary ingredients and nutritional supplements in the United States. Additionally, the company provides consulting services to third parties involved in cannabis cultivation, offering expertise in planning, design, and regulatory compliance. The company aims to capitalize on the growing demand for health and wellness products and the evolving legal cannabis market.
What do analysts say about ARGC stock?
There is limited analyst coverage for Arion Group Corp. due to its small market capitalization and OTC listing. Key valuation metrics, such as the negative P/E ratio, reflect the company's current lack of profitability. Growth considerations include the potential for revenue growth in the dietary supplement and cannabis consulting markets, but this is subject to regulatory risks and market volatility. Investors should conduct their own thorough research before investing.
What are the main risks for ARGC?
The main risks for Arion Group Corp. include its negative profit margin and lack of profitability, which pose a significant financial challenge. The company also faces regulatory risks in the cannabis industry and intense competition in the dietary supplement market. As an OTC-listed company with limited financial disclosure, Arion Group Corp. carries higher investment risks compared to companies listed on major exchanges. Low trading volume and liquidity can also lead to price volatility.
How does Arion Group Corp. generate revenue?
Arion Group Corp. generates revenue through two primary streams. First, it sells dietary ingredients and nutritional supplements to consumers. Second, it earns fees by providing consulting services to third-party cannabis cultivators. These consulting services encompass planning, design, and ensuring compliance with relevant regulations. The company's revenue is thus dependent on both consumer demand for supplements and the growth and regulatory landscape of the cannabis industry.
What are the key challenges facing Arion Group Corp. in the financial services sector?
Arion Group Corp. faces several key challenges. Its negative profit margin and lack of profitability are major concerns, requiring significant operational improvements. The company operates in highly competitive markets, necessitating differentiation and strategic partnerships. Regulatory uncertainties in the cannabis industry pose additional risks. Furthermore, as an OTC-listed company, Arion Group Corp. must overcome challenges related to limited financial disclosure and liquidity.
What are the key factors to evaluate for ARGC?
Arion Group Corp. (ARGC) currently holds an AI score of 45/100, indicating low score. Key strength: Involvement in the growing dietary supplement market.. Primary risk to monitor: Potential: Changes in regulations could negatively impact the cannabis consulting business.. This is not financial advice.
How frequently does ARGC data refresh on this page?
ARGC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ARGC's recent stock price performance?
Recent price movement in Arion Group Corp. (ARGC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Involvement in the growing dietary supplement market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data may not be fully up-to-date.